Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C20H19ClN4O4S and a molecular weight of approximately 446.9 g/mol. It features a thieno[2,3-b]pyrrole core linked to a tetrahydroquinoline moiety via an amide bond and contains both chloro and hydroxyethylamino substituents. The compound is listed in DrugBank as DB07792 and classified as experimental; it does not have an assigned therapeutic indication or established mechanism of action in humans. Its structure suggests potential for biological activity—possibly as an enzyme inhibitor or receptor modulator—but no specific pharmacological target or clinical use has been documented in public databases to date[7][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (S)-2-chloro-N-(1-(2-(2-hydroxyethylamino)-2-oxoethyl)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-6H-thieno[2,3-b]pyrrole-5-carboxamide.